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ABSTRACT: Real-time measurements of many low-abundance volatile
organic compounds (VOCs) in breath and air samples are already
feasible due to progress in analytical technologies, such as proton transfer
reaction mass spectrometry (PTR-MS). Nevertheless, the information
content of real-time measurements is not fully exploited, due to the lack
of suitable data handling methods. This study develops a data scientiﬁc
procedure to enhance data analysis and interpretation of longitudinal,
multivariate data sets from real-time, in vivo, aroma-release studies. The
developed procedure includes an automated data preprocessing and a
multivariate assessment of the test panel performance. A large
multifactorial PTR-MS data set is investigated that includes four
experimental protocols, two tested food products, four aroma
compounds, and eight panelists. Real-time measurements are converted
into standardized breath proﬁles by preprocessing, and 10 kinetic parameters are derived. Next to this, panel performance is
evaluated per experimental protocol and food product. Comprehensive information about panel performance, individual
panelists, studied products, aroma compounds, and kinetic parameters is extracted, demonstrating the great value of the
developed approach.
Real-time measurements of many low-abundance volatileorganic compounds (VOCs) in breath and air samples are
currently feasible by using, for example, proton transfer reaction
mass spectrometry (PTR-MS)1−4 and atmospheric pressure
chemical ionization source mass spectrometry (APCI-MS).5−8
These measurements can be used in diﬀerent ﬁelds including:
(a) clinical applications, such as online monitoring of
(patho)physiologically induced breath biomarker pro-
ﬁles2 and pharmacokinetics investigations of drugs
eliminated or absorbed by the respiratory tract9
(b) process analysis: for example, online monitoring of
VOCs in oﬀ-line gases of bioreactors10
(c) food and nutritional applications: for example, in online
in vivo retronasal ﬂavor release analysis6
By analyzing concentrations of VOCs over time, new insights
could be gained. These insights are not only about dynamics of
the processes involved but also about the eﬀect of diﬀerent
perturbations on these processes, such as the eﬀect of the food
matrix on aroma release.
Real-time measurements provide longitudinal, multivariate
data sets, which contain information about time courses of the
monitored VOCs. Longitudinal multivariate data sets can be
analyzed directly with various approaches11 or indirectly by
deriving a plethora of kinetic parameters. Kinetic parameters
such as the maximum intensity time and the half-life time are
commonly used in pharmacokinetic and nutrikinetic stud-
ies.9,12,13 However, currently used procedures for data analysis
and interpretation of real-time VOC proﬁles are very limited,
especially in breath analysis. In such studies, exhaled air from
spontaneously breathing patients or volunteers is analyzed. This
yields real-time proﬁles with a breathing pattern that is variable
in frequency and intensity between volunteers and experimental
conditions; this signiﬁcantly hampers analysis of real-time
breath proﬁles.
At present, no procedure for synchronization and stand-
ardization of real-time breath measurements is available.
Current data scientiﬁc procedures are conﬁned to directly
calculating or reading kinetic parameters such as Cmax
(maximum concentration), Tmax (time of maximum concen-
tration), and AUC (area under curve in a plot concentrations vs
time) from real-time proﬁles,7,14 collecting maximum concen-
trations from the few selected breaths15 or smoothing of real-
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time proﬁles to obtain estimations of time trajectories.16,17
These methods provide a limited description of time courses.
The description allows only a basic interpretation of breath
proﬁles, for example, by standard univariate tests, such as
analysis of variance (ANOVA).
The aim of this paper is to develop a comprehensive data
scientiﬁc procedure to enhance data analysis and interpretation
of real-time measurements from in vivo, aroma-release studies.
The procedure includes both an automated data preprocessing
of real-time breath measurements and a multivariate assessment
of derived kinetic parameters.
The main steps of the procedure are described in the
Procedure section, and experimental settings are given in the
Methods section. The procedure was successfully tested on a
large data set measured by PTR-MS in an in vivo aroma-release
study (see Materials). This data set was collected to select an
experimental protocol with optimal panel performance.
Application of the developed procedure is described in the
Results section. It includes standardization of time proﬁles,
derivatization of 10 kinetic parameters, and comprehensive
evaluation of panel performance in diﬀerent protocols. Panel
performance was assessed by considering the repeatability of
the panel and of individual panelists as well as the
discrimination power of the panel to distinguish between the
two tested food products. Multivariate methods were
introduced and applied for this purpose, the ﬁrst time such
methods are applied to in vivo ﬂavor-release studies.
Advantages of our procedure in reference to currently used
strategies are apparent (see Discussion. A comprehensive
interpretation of diﬀerences between experimental protocols in
the analyzed study is provided and discussed in the Discussion
section.
■ PROCEDURE
The ﬁrst part of the developed procedure involves an
automated data preprocessing which consists of:
1. baseline correction,
2. detection of the starting and ending points of each breath
stroke for a given reference ion,
3. transformation of real-time measurements into breath-
by-breath proﬁles,
4. standardization of breath-by-breath proﬁles,
5. derivation of kinetic parameters.
These steps are presented in Figure 1. Implemented methods
are brieﬂy described below and in detail in the Methods section.
In Figure 1A, the real-time measurements of acetone (a
reference ion; a ubiquitous, abundant compound in breath18)
and one of the monitored ions (ethyl octanoate) are shown.
Start, product, and swallow time are displayed. Clear breath
pattern, with regular breath strokes, is visible for acetone, and a
less regular pattern is observed for ethyl octanoate.
During preprocessing in step 1, any drift of the baseline is
corrected. The aim of step 2 is to extract the breath pattern of
acetone to use it in step 3. The starting and ending points of
each breath stroke for a given reference ion are detected by
minima detection (Figure 1B). Starting and ending points
corresponding to thin peaks (i.e., not breath strokes) with areas
smaller than 25% are not included in step 3.
In step 3, the real-time measurements are transformed into
breath-by-breath proﬁles in order to eliminate diﬀerences of
breath pattern frequency and intensity between volunteers and
experimental conditions. Breath areas from the real-time
measurements of ethyl octanoate are calculated with a
trapezoidal numerical integration method for each breath
using the detected starting and ending points of each breath
stroke from step 2. Breath-by-breath proﬁles are obtained by
sorting breath areas according to their order in time i.e. ﬁrst,
second, third, ..., last collected breath area (Figure 1C).
In step 4, standardization of ethyl octanoate breath-by-breath
proﬁles takes place. The developed procedure consists of both
Figure 1. Transformation of real-time measurements into standardized
breath-by-breath proﬁles during developed preprocessing procedure.
Panel A: original real-time measurements for two compounds: acetone
(reference ion) and ethyl octanoate (monitored ion) for panelist p1,
following protocol A and processing product f f. Start, product, and
swallow times are indicated. Panel B: real-time measurements after
baseline correction and detection of the starting and ending points of
the breath strokes for the acetone. Panel C: breath-by-breath proﬁles
of ethyl octanoate calculated with the trapezoidal numerical integration
method, using the start and end points from the previous step (B).
Panel D: breath-by-breath proﬁles of ethyl octanoate after
administering the product.
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normalization to acetone breath-by-breath proﬁles and
correction for background levels of ethyl octanoate in breath
before product administration. The normalization to acetone
breath-by-breath proﬁles was not performed in this study.
Breath-by-breath proﬁles of ethyl octanoate are standardized
only by background levels of ethyl octanoate in breath before
product administration i.e. the blank period (step 4, Figure
1D). The breath proﬁle of the product period is corrected by
subtracting the mean breath area of the blank period from each
breath area from the product period. Before standardization,
breaths in the blank period are checked for outliers (i.e., any
breaths with areas larger than twice the mean breath area of the
ﬁrst two breaths in the product period). This rule was
optimized and corresponds well to the outlier detection with
visual inspection. Outliers are eliminated.
In the ﬁnal step of preprocessing, 10 kinetic parameters
describing the release kinetics of each compound are derived
(Figure 2 and Table 2). These parameters are derived either
from standardized breath-by-breath proﬁles or from real-time
measurements after baseline correction as described in
Methods.
After preprocessing of all real-time measurements of a
considered data set (see Materials), the preprocessed data set
includes 2 food products, 4 protocols, 8 panelists, 5 repetitions,
4 compounds, and 10 kinetic parameters.
In the second part of the developed procedure, the
preprocessed data set is used to evaluate panel performance
in each of the four considered experimental protocols. The
repeatability of each individual panelist and the panel as well as
discriminant power of the panel are evaluated. Univariate and
multivariate methods are employed (see Methods).
The repeatability of each individual panelist is assessed with a
measure adapted from Rossi.19 The repeatability of the panel in
each protocol is assessed by means of the pooled variance over
all panelists. Both repeatability measures are calculated for each
protocol, product, ion, and kinetic parameter combination.
First, the panel repeatability is evaluated with standard
univariate tests (ANOVA and Wilcoxon tests) separately for
every ion, kinetic parameter, and product combination. Second,
individual panelist repeatabilities of all ion and parameter
combinations are included in principal component analysis
(PCA). For between protocol comparisons, PCA is performed
on data from all protocols. To explore diﬀerences within each
protocol, PCA is performed per protocol.
To evaluate discrimination power of each experimental
protocol, diﬀerences between two products are assessed with
standard univariate tests (Wilcoxon tests) separately for every
ion, kinetic parameter and protocol combination. Moreover,
multilevel partial least squares discriminant analysis (ML-PLS-
DA) is employed. Four ML-PLS-DA models are built, one for
each protocol. They include kinetic parameter levels for all ion
and parameter combinations. The discrimination power of the
protocols is assessed comparing performance measures of ML-
PLS-DA models.
Finally, outcomes of univariate and multivariate evaluation
are compared and combined. This provides an enhanced
interpretation of diﬀerences in panel performance. Comple-
mentary information about individual panelists, studied
products, aroma compounds and kinetic parameters, is
extracted, demonstrating the strength of the developed
procedure.
■ EXPERIMENTAL SECTION
Materials. Products and Their Preparation. Two products
are tested: product f f (full fat milk) and ss (aqueous sugar
solution). They both contain four aroma compounds: acetoin,
anisaldehyde, ethyl butyrate, and ethyl octanoate (see Table 1)
at a concentration of 135, 137, 93, and 135 ppm, respectively.
These compounds are aroma compounds commonly present in
food products and are able to be detected by PTR-MS. They
were speciﬁcally selected in this study to span two groups of
aroma compounds: esters and aldehydes and compounds with a
wide range of physiochemical properties such as log P
(partition coeﬃcient between oil and water, a measure of
lipophilicity) and Ka/w (partition coeﬃcient between air and
water, a measure of volatility).
Figure 2. Deriving kinetic parameters: total area under the curve
(AUCtotal), maximum breath area (Areamax), area under the curve
before swallow (AUCpre), maximum breath area before swallow
(Areamax_pre), area under the curve after swallow (AUCpost), time
required to reach 20% of maximum breath area after time of maximum
breath area (T20+), time required to reach 20% of maximum breath
area before time of maximum breath area (T20−), diﬀerence between
T20+ and T20− (ΔT20). Time of maximum intensity (Tmax) and
maximum intensity (Cmax) are read from real-time measurement after
baseline correction.
Table 1. Aromatic Compounds and Monitored Ions
compound CAS molecular weight/Da ion monitored in PTR-MS m/z log Pb Ka/w
c odor description
acetoin 513-86-0 88.11 87a −0.32 4.21 × 10−4 buttery, pastry
ethyl butyrate 105-54-4 116.16 117 1.85 1.63 × 10−2 fruity, orange, pineapple
anisaldehyde 123-11-5 136.15 137 1.76 3.25 × 10−5 anise, sambuca, ouzo
ethyl octanoate 106-32-1 172.27 173 3.81 5.19 × 10−2 fruity
aPTR-MS typically allows product ions to be monitored at the molecular mass of the compound +1 Da. In the case of acetoin, fragmentation and
loss of H2 occurs, and thus, the product ion is detected at −1 Da. blog P − partition coeﬃcient between oil and water, a measure of lipophilicity cKa/w
− partition coeﬃcient between air and water, a measure of volatility
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Product f f (full fat milk) has an addition of sugar at 3%
concentration. Product ss has a 10% sugar solution. Please see
Supporting Information for more details.
Panelists. Eight trained panelists (p1−p8) are included in
this study comprising 4 female and 4 male volunteers, aged 18−
65.
Protocols. Four experimental protocols (A, B, C and D) are
tested in this study. A single assay with each protocol lasts for 2
min. First, for a duration of 20 s, room air is sampled, after
which panelists position the sample device (see below) in their
nostrils. The panelists are asked to take four regular breaths and
then to administer the product, as indicated in Figure 1A. The
time of starting the PTR-MS measurement (start), the time at
which the product is administered (product), and the time of
the ﬁrst swallow and other swallows (swallow times) are
recorded for each assay. A 5 mL, plastic syringe is used by each
panelist to administer 5 mL of the sample in the mouth.
Protocol A is a reference protocol. During this protocol,
panelists have a free breathing pattern and swallow the ingested
product only once, according to their preference. In protocol B,
panelists also have a freely chosen breathing pattern but are
instructed to swallow 20 s after the product is introduced.
During protocol C, the breathing pattern of each panelist is
synchronized to a regularly beating, external sound (72 beats
per minute). Each panelist swallows once every 20 s after
administering the product. In protocol D, panelists have a freely
chosen breathing pattern and swallow four times: ﬁrst, 20 s
after the product was introduced and every 20 s, thereafter.
The panelists received instructions beforehand and had time
to practice the protocols and familiarize themselves with the
equipment. Between each assay, panelists are asked to cleanse
their mouth, rinsing with water. For each protocol, product, and
panelist, assays were repeated ﬁve times. That lead to 320
assays measured by the PTR-MS equipment. Due to an error in
data collection, two data ﬁles were incorrectly saved, giving 318
assays to be included in this study.
Methods. Breath Volatile Measurement by PTR-MS. The
instrument used for measurement was a high sensitivity PTR-
QMS coupled with a specialized inlet system for nose-space
analysis (Ionicon Analytick GmbH, Innsbruck, Austria).
Samples were measured with a multiple ion detection (MID)
setting to observe ions at m/z 21, 37, 59, 87, 117, 137, and 173,
and m/z 21 and 37 correspond to reagent ions in PTR-MS; m/
z 59 is the product ion of acetone. Other m/z values monitored
relate to the aroma compounds, as indicated in Table 1. Please
see Supporting Information for more details.
Baseline Correction. Assymetric Least Squares (ALS)20 with
the Whittaker smoother and baseline parameters (p = 10 and λ
= 0.0001) were used to correct for the baseline of real-time
measurements.
Detection of Breath Peak Minima in a Reference Ion
Proﬁle. Extrema function21 was used to detect minima
corresponding to the starting and ending time points of breath
strokes.
Deriving Kinetic Parameters. The maximum intensity in the
product period (Cmax) and the time when this occurs (Tmax) are
obtained from the real-time measurements after baseline
correction. Areas under the curve (AUCtotal, AUCpre and
AUCpost) are obtained by summing the breath areas in the total
product period and the before and af ter swallowing periods,
respectively. By selecting the maximum breath areas in a
product period or before swallow period, maximum breath areas
(i.e., Areamax and Areamax_pre) are collected, respectively. The
two time points when 20% of Areamax are reached (i.e., before
and after Tmax_breath) are recorded as T20− and T20+,
respectively,22 where the times are recorded as the mean time
of the relevant breath. Kinetic parameter ΔT20 is calculated as
the time diﬀerence between T20− and T20+.
Individual Panelist Repeatability. The repeatability of each
individual panelist is a measure of repeatability provided by
Mandel23 and adapted by Rossi19 eq 1:
=
S
Sj
individual panelist repeatability ij
(1)
where Sij is the standard deviation of the repetitions (in most
cases 5) from each panelist calculated separately for each
combination of protocol, product, ion, and kinetic parameter; Sj
is the pooled standard deviation over all panelists calculated
separately for each combination of protocol, product, ion, and
kinetic parameter. The closer the value of repeatability to 0, the
more consistent a panelist is relative to the overall group.
Univariate Evaluation of Panel Performance. ANOVA
models and Wilcoxon signed rank tests (α = 0.05) are used.
False discovery rate correction was performed by the Benjamini
and Hochberg method24 with a q-value = 0.05. More details on
performed analysis can be found in Supporting Information.
Multivariate Evaluation of Panel Performance. PCA is
performed on individual panelist repeatabilities separately for
each product. The data is autoscaled before PCA. To explore
diﬀerences within each protocol, PCA is performed per
protocol. It includes repeatabilities of panelists and ions in a
sample mode (n = 32) and kinetic parameters in a variables
mode (p = 10). For between protocol comparisons, PCA is
performed on data from all protocols. It consists of
repeatabilities of panelists and ions in a sample mode (n =
32) and kinetic parameters with protocols in a variables mode
(p = 40).
ML-PLS-DA models are double cross validated and include
variable selection.25,26 In a 7-fold double cross validated (2CV,
external loop), all samples of the same panelist were taken aside
as a test set (8 or 10 samples for a panelist), and the rest (a rest
set) is used in the model optimization in 1CV (internal loop).
During 5-fold single cross validation (1CV), the optimal
number of latent variables and an optimal set of variables (5-
step variable selection) are chosen. The performance of the
model is evaluated on the basis of performance parameters: the
area under the receiver operating curve (AUROC) and
percentage of misclassiﬁed samples (%NMC)27 derived from
predictions of the test samples in 2CV. The statistical
signiﬁcance of the model performance and the selected
variables is assessed with 2000 permutations.
Software. All statistical analyses are performed using Matlab
(version 2014a, The MathWorks, Natick, Massachusetts,
U.S.A.). The statistical toolbox of Matlab and house-written
code (available on request) is used.
Hardware. The computer used in this study was Intel Xeon
CPU E5−1620 3.6 GHz, 64GB RAM.
■ RESULTS
Data Preprocessing Procedure at Work. As an example
for the data preprocessing procedure Figure 1A shows real-time
proﬁles of acetone (a reference ion, m/z 59) and ethyl
octanoate (m/z 173). The presented data was collected from
panelist p1 using product f f performing protocol A. Similar
breath patterns are detected for other monitored ions
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(Supplementary Figure 1), panelists, and products. Diﬀerences
in signal intensity are evident with the most abundant ion from
ethyl butyrate (m/z 117, Supplementary Figure 1C) and the
least abundant ion from acetoin (m/z 87, Supplementary
Figure 1B).
During preprocessing with our procedure the real-time
proﬁles are transformed into breath-by-breath proﬁles (as
described in the sections Procedure and Methods).
Examples of standardized breath-by-breath proﬁles of all four
monitored ions are presented in Supplementary Figure 2 (for
panelist p1 with product f f following protocol A). Already after
this stage of preprocessing, direct observations can be made on
the release proﬁles of the monitored compounds. For example,
it can be seen that retro-nasal release of all monitored
compounds occurs mainly after the ﬁrst swallow in the fourth
breath. After the fourth breath, an exponential decrease in
compound intensities can be observed. For ethyl butyrate and
ethyl octanoate a signiﬁcant amount of the compound is also
present in a period before the ﬁrst swallow, in the ﬁrst breath.
In the ﬁnal step of preprocessing, 10 parameters, describing
release kinetics, are successfully derived (Figure 2). These
parameters are used during assessment of the panel perform-
ance. For example, Table 2 presents the mean levels and
standard deviations of the kinetic parameters for the four
compounds in the two products: f f and ss including all
protocols. The mean levels of kinetic parameters (e.g.,
AUCtotal) are in a good agreement with the observations
made based on the breath-by-breath proﬁles (Supplementary
Figure 2) and the real-time proﬁles (Supplementary Figure 1).
A large spread of values is observed over the four protocols,
evidenced by relatively large standard deviations. This variation
is greatly reduced when the data is analyzed per protocol.
Nevertheless, slight diﬀerences between the products f f and ss
can already be observed within the standard deviation, such as
for the ions ethyl butyrate and ethyl octanoate and parameters
AUCtotal, Areamax_pre, and AUCpre. Results of more detailed
analysis of the diﬀerences between products and protocols are
presented in the next paragraphs.
Panel Repeatability. First, standard ANOVA models are
employed to assess panel repeatability and homogeneity.
Repetition was not found to be a signiﬁcant factor for any of
these models. However, many signiﬁcant interactions between
panelists and protocols are found (see Supplementary Figure
3). This means that the panel is heterogeneous in relation to
the experimental protocol. It is true especially for acetoin and
anisaldehyde for which monitored ions are present in relatively
low levels (see Table 2); as such, they are more sensitive to the
characteristics of the experimental protocol.
From this univariate analysis, it can be concluded that
panelists are performing diﬀerently in diﬀerent protocols,
providing diﬀerent release proﬁles of monitored compounds.
One protocol with the best repeatability should be selected for
all panelists to avoid such interaction eﬀects. Repeatability
within each protocol and between diﬀerent protocols is
evaluated and described below.
Repeatability within Each Protocol. Grouping of the
samples, coming from diﬀerent ions of the same panelist, can
be observed in PCA scatterplots (Supplementary Figures 4 and
5) for all products and protocols. The samples coming from
panelist p6 are well separated from other samples in PC1
direction. Panelist p6 was identiﬁed as an outlier after further
detailed inspection of the kinetic parameter values of this
panelist, which showed to be very irreproducible. The data
from panelist p6 is discarded from further analysis hereafter.
PCA was repeated for the data of the remaining seven
panelists (Supplementary Figure 6 and 7). Similar grouping of
the samples, coming from diﬀerent ions of the same panelist,
can be seen as when p6 was included, but without clear
separations of panelists. Correlations can be observed between
repeatability obtained for diﬀerent kinetic parameters (PCA
loading plots, results not shown). The individual panelist
repeatability of AUCtotal, Areamax, AUCpost, and Cmax are usually
highly correlated (similar loading directions in PCA, ﬁrst group
of parameters) and responsible for the distribution of samples
in PC1 (accounting for 41−49% of explained variance).
Another group of correlated parameters (containing T20+,
T20−, and Tmax, second group of parameters) contributes mainly
to PC2 (accounting for 16−21% of explained variance). A third
group of parameters, comprising Areamax_pre and AUCpre, as well
as stand-alone ΔT20, are contributing both to PC1 and PC2.
Repeatability between Diﬀerent Protocols. For both
products, some grouping of samples from the same panelist
can be seen when score plots of PC1 vs PC2 for product f f and
PC1 vs PC3 for product ss are studied (Supplementary Figure
8). Repeatability of kinetic parameters in protocol A (a
reference protocol) is the main contributor to PC1 direction
(accounting for 21% for product f f and 33% for product ss).
Repeatability of the individual panelist in protocol A is lower
than for other protocols, especially for product ss. No clear
trends in diﬀerences between repeatability of kinetic parameters
in other protocols: B, C, and D can be seen.
Table 2. Mean Levels and Standard Deviations of Kinetic Parameters Derived from Preprocessed Data of Four Monitored
Compounds in Two Products: f f and ss
kinetic parameter
acetoin ethyl butyrate anisaldehyde ethyl octanoate
product f f product ss product f f product ss product f f product ss product f f product ss
mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD
1 AUCtotal [au] 89 60 94 61 19000 21000 27000 32000 270 180 300 200 2400 1800 3500 3400
2 Areamax [au] 24 17 24 19 7300 6600 9600 11000 93 86 120 130 450 310 1100 1400
3 AUCpre [au] 7 8 7 8 3600 5600 7500 9700 11 14 18 21 88 135 1200 1500
4 Areamax_pre [au] 15 24 16 25 8000 16000 15000 26000 23 35 36 50 216 370 1900 2600
5 AUCpost [au] 75 54 78 52 11000 11000 12000 13000 250 180 270 190 2200 1700 1600 1600
6 T20+ [s] 40 12 40 14 29 11 28 11 37 10 35 9 53 17 31 15
7 T20− [s] 17 8 17 9 17 10 16 10 18 7 17 7 18 10 17 14
8 ΔT20 [s] 22 10 23 12 12 5 11 4 20 8 17 7 35 16 14 7
9 Tmax [s] 21 9 21 11 18 14 16 14 22 7 20 8 26 16 15 16
10 Cmax [au] 25 15 25 15 12000 11000 20000 18000 72 53 95 83 390 260 2700 2600
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Figure 2 and Supplementary Figure 9 show the pooled
variance of protocols B, C, and D standardized to the pooled
variance of the reference protocol A. The panel’s repeatability
in the protocols B, C, and D is signiﬁcantly better (see
Supplementary Table 1) than in protocol A for both products.
However, the repeatability of the kinetic parameters T20− and
Tmax in protocol D, for product f f with ethyl butyrate (m/z
117) and with ethyl octanoate (m/z 173) is much lower (up to
12-fold) than in other protocols (Supplementary Figure 9D and
9F). This is mostly related to the multiple swallows in protocol
D, which cause additional release peaks of ethyl butyrate and
ethyl octanoate. The intensity of these peaks is ﬂuctuating,
resulting in high variability in determining Tmax and T20−.
For product ss, the strongest improvement in panel
repeatability can be observed for the most controlled protocol,
protocol C (Figure 3 and Supplementary Figure 9A,B),
especially for parameters relating to release before swallowing.
Similarly to product f f, decrease in repeatability of T20− and
Tmax for ethyl butyrate and ethyl octanoate, is present.
However, it is observed on a smaller scale and includes acetoin
as well. This can be explained by a lack of lipophilic phase in
the matrix of product ss and is further discussed in the
Discussion section.
When the observed diﬀerences between the protocols are
compared between products, lower signiﬁcance levels are
observed for product ss (Supplementary Table 1). For product
ss, protocol C is clearly the protocol with the highest panel
repeatability. It is signiﬁcantly better in comparison with all
protocols (including protocol B and D).
Discrimination Power of Diﬀerent Protocols. According to
the univariate analysis results (Supplementary Figure 10), it
cannot be concluded which protocol is characterized with the
greatest discrimination power. Diﬀerences between products
are both protocol- and compound-dependent. No diﬀerences
between products can be observed for acetoin. In the case of
ethyl octanoate, many signiﬁcant diﬀerences can be reported.
These are mainly related to increased levels of Areamax_pre,
AUCpre and Cmax and decreased levels of T20+, ΔT20, and Tmax in
product ss when compared with f f (see Table 2). For ethyl
butyrate, signiﬁcant diﬀerences are observed in protocol B and
C for Areamax_pre, AUCpre, and Cmax. These parameters have
signiﬁcantly higher levels for product ss when compared with
product f f, in line with an expected quicker release from nonfat-
containing matrices leading to higher intensities in the earlier
part of the release curve. For anisaldehyde, signiﬁcant
diﬀerences are observed for protocols A and D and include
diﬀerent parameters (protocol A: AUCtotal, Areamax, AUCpost,
Cmax, protocol D: Areamax_pre, ΔT20, Tmax, Cmax). Signiﬁcant
parameters in protocol A have higher values in product ss than
in product f f. Areamax_pre and Cmax have signiﬁcantly higher
values in product ss than f f in protocol D. In contrast, ΔT20 and
Tmax have lower values in product ss than f f in protocol D, again
in line with expectation.
Results of multivariate analysis of discrimination power of
diﬀerent protocols are presented in Table 3. It can be observed
that all protocols are characterized as having a very good
discrimination power (NMC% < 17% and AUROC > 0.91).
The best model performance is obtained for protocol D. The
second best is protocol C. The variables important for
discrimination of products include mainly kinetic parameters
of ethyl octanoate conﬁrming ﬁndings of univariate analysis.
These are i173_T20+, i173_ΔT20, 3−i173_Cmax, and
i173_AUCpre. This ﬁnding indicates that the discriminating
power of each protocol is mainly dependent on the kinetic
parameters of ethyl octanoate; the release of other compounds
from the two products is similar. This is expected, because the
release of the highly lipophilic ethyl octanoate will be
considerably more inﬂuenced than that of the other
compounds by the presence of an oil phase, which functions
as a sink.
■ DISCUSSION
Developed Procedure. In our procedure, the breathing
pattern indicated by acetone (reference ion) is used to
transform unsynchronized time proﬁles of the monitored ions
into synchronized breath proﬁles. According to our knowledge,
this is the most accurate preprocessing approach available to
obtain release proﬁles. Other approaches are much less exact,
such as smoothing of the time proﬁle16 or manually taking the
maximum intensity of breath peaks.14 In addition, incorporating
the normalization of breath proﬁles by a blank period corrects
for diﬀerences between baseline levels in diﬀerent panelists.
That makes further comparison between panelists more
relevant.
The presented preprocessing approach is fully automated
and user-independent. The user input is limited to the loading
of the PTR-MS data ﬁles and a ﬁle with starting, product and
swallow times. The complete data preprocessing of the 318
assays took less than 10 min of computational time. This is a
substantial improvement when compared with manual
Figure 3. Pooled variance of the panel for four experimental protocols:
A, B, C, and D for anisaldehyde and product ss. Pooled variance of
protocol A is taken as a reference, and values of pooled variance of all
protocols are normalized to that of protocol A.
Table 3. Results of Multilevel-PLS-DA Modeling of
Diﬀerences between Product f f and ss in Four Protocols
protocol
model performance
signiﬁcant variablesc (p-values)NMCa(%) AUROCb
A 16.3 0.91 1 (0.008), 2(0.002), 3(0.0325)
B 11.8 0.94 1(0.0005), 2(0.0045), 3(0.0255),
4 (0.0405)
C 8.9 0.96 1 (0.0005), 2(0.008),
D 4.0 0.99 1(0.01), 2(0.0035), 5(0.0425),
aNMC(%) − % of misclassiﬁed samples. bAUROC − area under
receiver operating curve. cSigniﬁcant variables: 1−i173_T20+, 2−i173_
ΔT20, 3−i173_ Cmax, 4−i173_ AUCpre, 5−i173_ AUCpost
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integration of breath patterns (for such a data set, typically a 2
week period).
A wide spectrum of kinetic parameters is provided with our
procedure and included in this study. It should be emphasized
that the derived parameters Tmax, T20+, T20−, and ΔT20 provide
additional information on release proﬁles (such as aroma
persistence), available only after data preprocessing. This
information can be used, for example, to detect irreproducible
experimental protocols (see the section Comparisons of Four
Experimental Protocols). In our procedure, a release proﬁle can
be automatically divided into a pre- and postswallowing period,
and the kinetic parameters can be more accurately described for
each period.22
In the ﬁnal step of the presented procedure, univariate and
multivariate tools are applied to assess diﬀerences between
products and experimental protocols. Multivariate analysis
became possible due to the availability of many parameters
derived with the preprocessing procedure. Therefore, PCA is
employed to study individual panelist repeatabilities for the ﬁrst
time. Moreover, ML-PLS-DA is used to detect product
diﬀerences in in vivo release studies, also for the ﬁrst time. It
should be stressed that including these multivariate tools
enabled identiﬁcation of crossover eﬀects between product
composition and experimental protocol. This was not possible
with only standard univariate tools such as ANOVA. Never-
theless, the used combination of methods leads to valuable
insights about changes in retro-nasal release of the four studied
compounds in the two products. Aforementioned outcomes are
discussed below.
Comparisons of Four Experimental Protocols. The
extent of retronasal aroma release is a physiological feature that
can be individually characterized.28 Subject diﬀerences in oral
processing parameters, such as salivary ﬂow rate, nasal anatomy,
bite size, and eating speed are (partly) responsible for this. Bite
size and duration of oral processing can be controlled in an
experimental protocol by a standardized amount of product
taken, ﬁxed time of mastication before the ﬁrst swallow and
secondary swallows.14,16,29 This was the case in our study, in
which three levels of control were implemented: a free protocol
with free time to the ﬁrst swallow (protocol A, a reference
protocol), protocols with ﬁxed time (20 s) to the ﬁrst swallow
(protocols B and C), and a protocol with a ﬁxed time to ﬁrst
and three secondary swallows (every 20 s, protocol D). The
additional control over breathing pattern was introduced in
protocol C, and this may inﬂuence repeatability of time proﬁles,
especially for untrained panelists.
As expected and shown in this study, the panel is
heterogeneous in relation to the experimental protocol. Each
panelist has diﬀerent levels of individual repeatability depend-
ent on experimental protocol and considered kinetic parame-
ters. The latter are grouped and correspond mainly to two
independent aspects of aroma release: initial release of volatiles
including ﬁrst swallow (1st group: AUCtotal, Areamax, AUCpost,
and Cmax) and the persistence of volatiles in breath (2nd group:
T20+, T20−, and Tmax). This is in agreement with the ﬁndings of
Hodgson et al.14 where inﬂuence of initial swallow and
secondary swallows was studied. Additionally, it gives a new
insight into the relationships between kinetic parameters and
the diﬀerences observed for diﬀerent protocols and panelists.
For both products, panel repeatability of protocols B, C, and
D was better than the reference protocol. The most controlled
protocol C was characterized with the best repeatability;
compared with all other protocols, the improvement in
repeatability was statistically signiﬁcant for aqueous product
ss. Protocol D gave very irreproducible results for T20− and Tmax
for the esters ethyl butyrate and ethyl octanoate, especially for
the full-fat milk matrix product, ﬀ. Taking this into account, we
do not recommend using this protocol for studying the release
of these lipophilic compounds, at least not in cases where time
parameters are in focus.
The signiﬁcant improvement in discrimination power for
protocols B, C, and D in comparison to free protocol A is
reported. This is in contrast to previously reported studies
where a free protocol had the highest discriminative ability.22
The most discriminative kinetic parameters were derived for
ethyl octanoate. For this compound, increased levels of
Areamax_pre, AUCpre, and Cmax and decreased levels of T20+,
ΔT20, and Tmax are reported in products with the aqueous sugar
solution matrix when compared with the full-fat milk matrix.
This is perfectly in line with the expected slower release of
lipophilic compounds from oil-containing matrices.
In the preswallow phase, the eﬀect of food composition is
expected to have the greatest eﬀect on volatile release. In the
postswallow phase, where most of the product is removed,
diﬀerences in the release are mainly attributed to properties of
the compounds (i.e., volatile partitioning in the fat, in the bolus,
and in masticated particles coating the mouth and throat).16
Results reported in this paper strictly correspond to the above
statements. The increase in Areamax_pre and AUCpre for the
product with sugar solution matrix is observed for all
compounds and is statistically relevant for ethyl octanoate
(for all protocols) and ethyl butyrate (for the protocols B and
C). Both esters, which are highly volatile (high Ka/w, see Table
1), are released to retronasal space more easily pre- and
postswallow than the two other considered compounds. Ethyl
octanoate has the strongest persistence after swallow (high T20+
and ΔT20 values) when compared with other compounds
(Table 2) because it is highly lipophilic (high log P) and stays
longer in the fat in the bolus of the f f product.
■ CONCLUSIONS
A comprehensive data analysis procedure was developed and
employed for the analysis of a large data set from the real-time,
in vivo aroma release study, using PTR-MS. It comprises an
automated data preprocessing procedure and multivariate
assessment of the panel performance. During preprocessing,
real-time breath proﬁles are converted into standardized breath
proﬁles and 10 kinetic parameters are derived and used to
describe the release kinetics of the aroma compounds. Next to
this, multivariate analysis enabled extracting and interpreting
complementary information about panel performance, individ-
ual panelists, studied products, aroma compounds, and kinetic
parameters.
The most controlled experimental protocol with one swallow
event and a controlled breathing pattern was selected as the
optimal one and is recommended in other in vivo release
studies.
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